COLLEYVILLE, TX--(Marketwire - February 21, 2008) - digiMedical Solutions, Inc. (
PINKSHEETS:
DGMS) announced today that the Company has signed a contract with
Christopher L. Wey, M.D, of Neuroscience and Spine Associates in Naples,
Florida, to implement the digiRX system and digiReauth call center
services. The system and services will take over the prescription
reauthorization processing and refill management service for Dr. Wey's
office. Separately, digiMedical recently announced increasing the sales
team in the Naples and Fort Myers, Florida, markets to increase the
Company's regional footprint and support the Company's $10 million 2008
revenue goal.
Dr. Christopher L. Wey stated, "The digiReauth system will increase our
office efficiency by taking over our inbound prescription re-authorization
and refill calls allowing our staff to focus on in-office patient care,
while still maintaining a high level of customer service to patients
needing re-authorized prescriptions. We are also very pleased with the
high level of digital security and readability the system lends to
prescription processing."
David W. Lee, Chief Executive Officer and Director for digiMedical
Solutions, commented, "digiReauth's digital prescription reauthorization
process and supporting customer service call center has proved to be a
great support to our doctors. We are pleased to be able to provide these
services to Dr. Wey at his clinic and look forward to expanding our
services with his clinic and other doctors in the region as we ramp up our
sales expansion in the area."
digiMedical Solutions, a Microsoft Partner, with operations in Texas and
Florida, has built its own suite of proprietary software to handle
prescriptions digitally from the physician's office to the pharmacy,
securely and in compliance with all DEA and HIPAA requirements. The suite
of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and now
digiAccounting and the Company owns and operates five pharmacies throughout
Texas and Florida.
To be added to digiMedical's corporate e-mail list for shareholders and
interested investors, please send an e-mail to
ir@digimedical.com.
About Neuroscience & Spine Associates (
www.neurosurgeon.com)
Neuroscience & Spine Associates (NASA) employs Southwest Florida's leading
practitioners in neurology, neurosurgery, rehabilitation and diagnostics.
The on-staff specialists have combined their expertise to provide the
highest quality, most technologically advanced patient care available from
a single medical clinic. Their board certified physicians and professional
staff are dedicated specialists in their field. Areas of service include:
-- MRI Center
-- Headache Center
-- Spine Care and Rehabilitation
-- Pain Management
-- Dementia
-- Balance/Dizziness
-- Nerve Disorders
-- Neurosurgery
About digiMedical Solutions, Inc.™
digiMedical Solutions, Inc.™ (
http://www.digimedical.com/) is a pharmacy
and medical technology company focused on developing next generation
digital medical technology with an emphasis on digital prescriptions
(d-Prescriptions) that will more closely align the doctor, pharmacist and
patient. The company's planned growth will come from three channels: direct
marketing of the company's wireless base d-prescription technology to
doctors, acquisition of independent pharmacy chains and the sale of certain
territories to "market partners" licensed to exploit the digiMedical
Solutions™ model. digiMedical Solutions, Inc.™ currently owns and
operates five (5) pharmacies located in Texas and Florida. digiMedical
Solutions™' unique business model brings doctor, patients and pharmacies
into next generation medical technologies.
Forward-Looking Statement
Statements included in this press release which are not historical in
nature, are intended to be, and are hereby identified as "Forward-Looking
Statements" for purposes of safe harbor provided by Section 21E of the
Securities Exchange Act of 1934, as amended. Forward Looking Statements may
be identified by words including "anticipate," "await," "envision,"
"foresee," "aim at," "believe," "intends," "estimates" including without
limitation, those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual results
to differ materially from those indicated in the
Forward-Looking Statements. Readers are directed to the company's filings
with the U.S. Securities and Exchange Commission for additional information
and a presentation of the risks and uncertainties that may affect the
company's business and results of operations.
Contact Information: Contact:
digiMedical Solutions, Inc.
Investor Relations
ir@digimedical.com
214-722-3029